Reshaping the future for life

We provide innovative devices, drugs, diagnostic reagents and services to improve the preservation, evaluation and transportation of transplanted organs, help transplant patients survive for a long time, and promote innovation and development in the field of transplantation.

Company Introduction

The company was founded in 2004 with a registered capital of RMB 70.4 million and 194 employees worldwide, including 46 R&D staff members.

The company focuses on organ transplantation as a provider of medical products and professional services for the global market around the entire transplant process.

Focusing on the needs of organ transplantation surgeons and patients, we provides medical devices and professional services related to organ transplantation, mainly involving products for the preservation, transportation, evaluation and repair of transplanted organs and in vitro diagnostic reagents for individualized and precise diagnosis of transplant patients, which are exported to about 46 countries and regions worldwide.

About Us

Core Values

Focus on transplantation


Respect Life


Continuous Innovation

Our Journey


-Starting distribution of over- seas transplant products ·
-Covering the transplant market in East China


-Set up manufacturing plant in Yunze IVD subsi- diary


- Completed LSI M&A
-Expanding to global market


• Received China NMPA approval for the first independently developed product G16



-Received FDA approval for G16



- Genext Founded


- Acting as Hisun exclusive distributor of immunosup- pressant to expand national sales


-Listed on China OTC market


-New R&D center established


-Received CE certification for all TDM products

Global Business

Head Office Location: Shanghai, China

Other office locations: Guangzhou

Chicago Brussels

Wholly Owed Subsidiary Company: Lifeline Scientific, Inc.

Global sales network - covering 46 countries

Asia: China, Philippines, Thailand, Singapore, India, South Korea

Europe: Austria, Belgium, Croatia, Czech Republic, Denmark, England, Estonia, France, Germany, Ireland, Italy, Latvia, Lithuania, Norway, Northern Ireland, Poland, Portugal, Romania, Scotland, Slovenia, Spain, Sweden, Switzerland, Netherlands, Wales, Turkey, Polynesia

North America: United States, Canada, Panama

South America: Brazil, Colombia, Peru, Argentina, Mexico

Middle East: Israel, Kuwait, Saudi Arabia

Africa: Algeria

Oceania: Australia

Company Strategy

Social Responsibility

Genext focuses on human organ transplantation. Leveraging on innovative technologies and services, the company hopes to help physicians and patients improve the long-term survival.

China-Australia "Xiangya-Westmead" Transplantation Summit, December 6, 2015
To support the development of organ transplantation in China:
The company has donated a total of RMB 3,252,000 to the China Organ Transplantation Development Foundation and co-sponsored the"Seedling Project” to help young transplant patients learn and grow.